Search research articles
Contact Us
Filters
Showing results (181-190 of 315) with videos related to
Page
of 32
Sort By:
Blood Advances
|
November 2, 2022
Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
Nataliya P Buxbaum, Gerard Socié, Geoffrey R Hill, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 22, 2011
Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts
Yi-Bin Chen, Julie Aldridge, Haesook T Kim, et al.
Blood
|
March 23, 2006
Rituximab for steroid-refractory chronic graft-versus-host disease
Corey Cutler, David Miklos, Haesook T Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2014
Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions
Matthias Piesche, Vincent T Ho, Haesook Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2017
Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
Mark A Exley, Phillip Friedlander, Nadia Alatrakchi, et al.
Blood
|
June 20, 2012
A disease risk index for patients undergoing allogeneic stem cell transplantation
Philippe Armand, Christopher J Gibson, Corey Cutler, et al.
Nature Communications
|
March 4, 2025
Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal tem cell deficiency: a phase I/II clinical trial of the first xenobiotic-free, serum-free, antibiotic-free manufacturing protocol developed in the US
Ula V Jurkunas, Aaron R Kaufman, Jia Yin, et al.
Blood
|
September 30, 2025
Mechanisms of immune escape and extramedullary tropism in leukemia cutis
Livius Penter, Katie Maurer, Nicoletta Cieri, et al.
Blood
|
July 18, 2013
Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
Corey Cutler, Haesook T Kim, Bhavjot Bindra, et al.
Cytotherapy
|
September 6, 2018
Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy
Joana M Murad, Susanne H Baumeister, Lillian Werner, et al.
Page
of 32
Search research articles
Search
Showing results (181-190 of 315) with videos related to
Sort By:
Page
of 32
Blood Advances
|
November 2, 2022
Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
Nataliya P Buxbaum, Gerard Socié, Geoffrey R Hill, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 22, 2011
Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts
Yi-Bin Chen, Julie Aldridge, Haesook T Kim, et al.
Blood
|
March 23, 2006
Rituximab for steroid-refractory chronic graft-versus-host disease
Corey Cutler, David Miklos, Haesook T Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2014
Angiogenic cytokines are antibody targets during graft-versus-leukemia reactions
Matthias Piesche, Vincent T Ho, Haesook Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2017
Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
Mark A Exley, Phillip Friedlander, Nadia Alatrakchi, et al.
Blood
|
June 20, 2012
A disease risk index for patients undergoing allogeneic stem cell transplantation
Philippe Armand, Christopher J Gibson, Corey Cutler, et al.
Nature Communications
|
March 4, 2025
Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal tem cell deficiency: a phase I/II clinical trial of the first xenobiotic-free, serum-free, antibiotic-free manufacturing protocol developed in the US
Ula V Jurkunas, Aaron R Kaufman, Jia Yin, et al.
Blood
|
September 30, 2025
Mechanisms of immune escape and extramedullary tropism in leukemia cutis
Livius Penter, Katie Maurer, Nicoletta Cieri, et al.
Blood
|
July 18, 2013
Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
Corey Cutler, Haesook T Kim, Bhavjot Bindra, et al.
Cytotherapy
|
September 6, 2018
Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy
Joana M Murad, Susanne H Baumeister, Lillian Werner, et al.
Page
of 32